First human tests begin for new drug candidate
NCT ID NCT06306872
Summary
This early-stage study tested the safety and how the body processes a new drug called ABSK061 in healthy adults. Researchers gave single and multiple doses of the tablets to 40 volunteers to check for side effects and see how food affects absorption. The goal was to gather basic safety data before testing in patients with specific conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214062, China
Conditions
Explore the condition pages connected to this study.